Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints
Doumas, Michael, Imprialos, Κonstantinos, Stavropoulos, Konstantinos, Reklou, Andromachi, Sachinidis, Alexandros, Athyros, Vasilios G
Published in Current pharmaceutical design (01.01.2018)
Published in Current pharmaceutical design (01.01.2018)
Get more information
Journal Article